STAT+: MD Anderson hit with ethics complaint over failure to disclose clinical trial results
An advocacy group has filed an ethics complaint with the University of Texas MD Anderson…
Category: clinical trials
STAT+: Europe’s largest clinical trial sponsors are getting better at reporting results
More than two dozen of the largest universities and hospitals in Europe have shown a…
STAT+: FDA tells drug makers to redo studies run by two contract research firms due to data integrity issues
In a rare move, the U.S. Food and Drug Administration has notified an untold number…
STAT+: U.K. government launches a new system to monitor clinical trial reporting
After a prolonged effort, the U.K. government is now tracking whether clinical trial sponsors are…
STAT+: Biogen trials for Alzheimer’s drug excluded much of the targeted patient pool, study finds
A new analysis finds that the clinical trials conducted by Biogen (BIIB) for its controversial…
.jpg)
STAT+: For the first time, the FDA warns a trial investigator for failing to report study results
In a little noticed warning, the Food and Drug Administration threatened to fine the principal…
STAT+: Inside Verily’s make-or-break push to turn its most promising ideas into profits
It’s a make or break moment for Verily, as the sprawling Google offshoot rapidly accelerates…
STAT+: Verily makes its first major acquisition as it looks to transform clinical trials
On the heels of a series of prominent recent hires, Verily announced plans on Tuesday…
.jpg)
STAT+: FDA threatens to fine another drug maker for failing to report clinical trial results
For only the second time, the Food and Drug Administration is threatening to fine a…
STAT+: Most clinical trials failed to meet U.S. transparency requirements for recently approved drugs
In the latest look at clinical trial transparency, a new analysis found that only 26%…
STAT+: ‘Some very noble, some less than noble’: The growing health data marketplace sparks concern over patient privacy
The electronic health record has ushered in a golden era of precision medicine. It’s also…
STAT+: In a possible sign of transparency, more leading universities are reporting clinical trial results
Over the past two years, many major U.S. universities have done a better job of…
STAT+: What deadline? Most clinical trials are still not reported on time to federal database
Amid ongoing calls for greater clinical trial transparency, a new analysis finds just 40% of…
STAT+: European regulatory body plans ‘joint action’ to bolster clinical trial reporting
The Heads of Medicines Agencies, an umbrella group for regulators in 30 European Union countries,…
STAT+: In Belgium, too many clinical trial sponsors waffle about reporting required results
The results of more than one-fifth of clinical trials that were conducted in Belgium have…
STAT+: For the first time, the FDA may fine a drug maker for failing to post clinical trial results
The Food and Drug Administration is threatening to fine Acceleron Pharma (XLRN) for failing to…
Virtual event: Increasing diversity in clinical trials
The Covid-19 pandemic has thrown into relief the long-standing racial inequities in the U.S. health…
Biogen to expand access to its ALS drug, but move may come too late for some patients
After weeks of controversy, Biogen (BIIB) has agreed to provide an experimental drug for combating…
STAT+: Thermo Fisher buys contract-research company PPD for $17.4 billion
Thermo Fisher Scientific announced Thursday that it will buy PPD, a contract-research company for the…
Huntington’s community grieves not just one therapeutic setback, but two
For the community of people affected by Huntington’s disease — a group that is no…
STAT+: Clinical study reports hold more details about the side effects of cancer drugs
For years, researchers have urged regulators to release clinical study reports that are generated during…
STAT+: How artificial intelligence could make clinical trials smarter
Clinical trials have a dirty little secret. For all the careful work that goes into…
Two ways Fitbit could boost Google’s health ambitions
Google’s newly-finalized purchase of Fitbit is poised to provide the tech giant with a potentially…
STAT+: ‘The trend is irreversible’: How Covid-19 could drive a shift toward decentralized trials
Covid-19 started as a disaster for clinical research, halting or delaying 3 of every 4…
STAT Plus: Seres announces positive late-stage results for its microbe-based drug
Four years after a devastating clinical trial failure, Seres Therapeutics seems to have found success….